Cargando…
Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
Due to limited systemic treatment options, peritoneal carcinomatosis of gastric origin is still associated with a dismal outcome and is claimed a terminal disease. In the past, surgery had not been considered as a potential treatment option. However, there is emerging evidence that in selected patie...
Autores principales: | Boerner, Thomas, Piso, Pompiliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619964/ https://www.ncbi.nlm.nih.gov/pubmed/34830545 http://dx.doi.org/10.3390/jcm10225263 |
Ejemplares similares
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004) -
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Glockzin, Gabriel, et al.
Publicado: (2009) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017) -
Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?
por: Duzgun, Ozgul, et al.
Publicado: (2021) -
Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014)